Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP913761.RA47F4t6DWpyryzj-_rLEP833K6JJp-WrZw3dgNA2wHbk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP913761.RA47F4t6DWpyryzj-_rLEP833K6JJp-WrZw3dgNA2wHbk130_assertion type Assertion NP913761.RA47F4t6DWpyryzj-_rLEP833K6JJp-WrZw3dgNA2wHbk130_head.
- NP913761.RA47F4t6DWpyryzj-_rLEP833K6JJp-WrZw3dgNA2wHbk130_assertion description "[The strongest c-erbB-2 immunoexpression was observed in low grade astrocytomas (diffuse astrocytomas G2); in the glioblastoma group the c-erbB-2 protein expression was weak and 17.4% of cases were negative.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913761.RA47F4t6DWpyryzj-_rLEP833K6JJp-WrZw3dgNA2wHbk130_provenance.
- NP913761.RA47F4t6DWpyryzj-_rLEP833K6JJp-WrZw3dgNA2wHbk130_assertion evidence source_evidence_literature NP913761.RA47F4t6DWpyryzj-_rLEP833K6JJp-WrZw3dgNA2wHbk130_provenance.
- NP913761.RA47F4t6DWpyryzj-_rLEP833K6JJp-WrZw3dgNA2wHbk130_assertion SIO_000772 21804458 NP913761.RA47F4t6DWpyryzj-_rLEP833K6JJp-WrZw3dgNA2wHbk130_provenance.
- NP913761.RA47F4t6DWpyryzj-_rLEP833K6JJp-WrZw3dgNA2wHbk130_assertion wasDerivedFrom befree-2016 NP913761.RA47F4t6DWpyryzj-_rLEP833K6JJp-WrZw3dgNA2wHbk130_provenance.
- NP913761.RA47F4t6DWpyryzj-_rLEP833K6JJp-WrZw3dgNA2wHbk130_assertion wasGeneratedBy ECO_0000203 NP913761.RA47F4t6DWpyryzj-_rLEP833K6JJp-WrZw3dgNA2wHbk130_provenance.